Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy.
COX-2
Cerebral ischemia
Excitotoxicity
Neuroinflammation
PGE(2)
mPGES-1
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
17
07
2020
revised:
28
08
2020
accepted:
05
10
2020
pubmed:
15
10
2020
medline:
18
11
2021
entrez:
14
10
2020
Statut:
ppublish
Résumé
Over the past two decades the interest has waned in therapeutically targeting cyclooxygenase-2 (COX-2) due to growing concerns over the potential cardiovascular and cerebrovascular toxicities of the long-term use of COX-2 inhibitors. Attention thus has recently been shifted downstream to the prostaglandin signaling pathways for new druggable anti-inflammatory targets aiming for higher therapeutic specificity. Prostaglandin E2 (PGE
Identifiants
pubmed: 33053444
pii: S1043-6618(20)31546-2
doi: 10.1016/j.phrs.2020.105238
pmc: PMC7854947
mid: NIHMS1637888
pii:
doi:
Substances chimiques
Receptors, Prostaglandin E
0
Cyclooxygenase 2
EC 1.14.99.1
Dinoprostone
K7Q1JQR04M
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105238Subventions
Organisme : NINDS NIH HHS
ID : R01 NS100947
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS109687
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Autophagy. 2014 Sep;10(9):1535-48
pubmed: 24988431
Neurochem Res. 2018 Feb;43(2):259-266
pubmed: 28975464
Neurosci Lett. 2008 Jun 20;438(2):210-5
pubmed: 18472336
J Neurosci. 2015 Aug 26;35(34):11791-810
pubmed: 26311764
Stroke. 2009 May;40(5):1849-57
pubmed: 19265055
J Neurosci. 1997 Apr 15;17(8):2746-55
pubmed: 9092596
J Cereb Blood Flow Metab. 2014 Feb;34(2):185-99
pubmed: 24281743
ACS Pharmacol Transl Sci. 2020 Jun 25;3(4):635-643
pubmed: 32832866
Sci Rep. 2015 Dec 09;5:17956
pubmed: 26648273
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11790-5
pubmed: 16864802
Front Cell Neurosci. 2015 Jan 14;8:461
pubmed: 25642168
Biol Pharm Bull. 2017;40(5):557-563
pubmed: 28458341
J Endod. 2016 Apr;42(4):584-8
pubmed: 26906242
J Cereb Blood Flow Metab. 2009 Jan;29(1):66-72
pubmed: 18648380
Toxicol Sci. 2006 Jan;89(1):265-70
pubmed: 16237196
Trends Pharmacol Sci. 2016 Jun;37(6):463-484
pubmed: 27062228
J Cereb Blood Flow Metab. 2004 Sep;24(9):945-63
pubmed: 15356416
J Clin Invest. 1999 Jun;103(11):1539-45
pubmed: 10359563
J Leukoc Biol. 2010 May;87(5):779-89
pubmed: 20130219
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
J Neurosci Res. 2010 Feb 1;88(2):381-90
pubmed: 19658194
Expert Opin Investig Drugs. 2015 May;24(5):623-43
pubmed: 25727670
Ann Neurol. 2003 Aug;54(2):155-62
pubmed: 12891667
CNS Neurosci Ther. 2012 Mar;18(3):250-60
pubmed: 22449108
Br J Pharmacol. 2010 Jun;160(4):847-59
pubmed: 20590584
Curr Med Chem. 2008;15(19):1863-9
pubmed: 18691044
Exp Neurol. 2009 May;217(1):63-73
pubmed: 19416671
J Neurosci Res. 2007 Aug 15;85(11):2433-40
pubmed: 17600836
Ann Neurol. 2005 May;57(5):758-61
pubmed: 15852374
Stroke. 2009 Aug;40(8):2945-8
pubmed: 19478221
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1294-9
pubmed: 11158633
Nat Med. 2006 Feb;12(2):225-9
pubmed: 16432513
Neurobiol Dis. 2015 Apr;76:126-136
pubmed: 25600211
J Neuroimmunol. 2007 Mar;184(1-2):172-9
pubmed: 17275922
J Neurosci. 2004 Jan 7;24(1):257-68
pubmed: 14715958
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10954-9
pubmed: 9724811
Trends Pharmacol Sci. 2013 Jul;34(7):413-23
pubmed: 23796953
Mol Neurobiol. 2015;51(3):1480-8
pubmed: 25095782
Nat Med. 2011 Jul 07;17(7):796-808
pubmed: 21738161
J Biol Chem. 2013 Mar 29;288(13):9293-302
pubmed: 23404506
Front Neurosci. 2018 Feb 20;12:89
pubmed: 29527151
Neurotherapeutics. 2016 Oct;13(4):791-800
pubmed: 27412685
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10501-6
pubmed: 10468638
J Biol Chem. 2008 May 2;283(18):12538-45
pubmed: 18230618
Stem Cells. 2016 Sep;34(9):2290-305
pubmed: 27301070
Prog Neurobiol. 2019 Dec;183:101682
pubmed: 31454545
J Clin Invest. 2006 Jan;116(1):4-15
pubmed: 16395396
Pharmacol Ther. 2020 May;209:107504
pubmed: 32088247
Placenta. 2006 Apr-May;27(4-5):395-401
pubmed: 15990166
Nat Med. 1999 Feb;5(2):217-20
pubmed: 9930871
Front Cell Neurosci. 2016 Mar 04;10:56
pubmed: 26973468
Stroke. 2016 Dec;47(12):3048-3052
pubmed: 27834752
Brain Res. 2003 Jan 17;960(1-2):273-6
pubmed: 12505683
Exp Transl Stroke Med. 2010 Jul 08;2(1):12
pubmed: 20615245
Epilepsia Open. 2020 Jun 09;5(3):418-431
pubmed: 32913950
Mol Brain. 2012 May 14;5:14
pubmed: 22583753
Mol Pharmacol. 1995 Nov;48(5):869-79
pubmed: 7476918
J Clin Invest. 2011 Nov;121(11):4362-71
pubmed: 21965326
Pharmacol Res. 2019 Sep;147:104349
pubmed: 31315064
J Neuroimmunol. 2011 Sep 15;238(1-2):34-43
pubmed: 21803432
Br J Pharmacol. 2010 Mar;159(5):1174-86
pubmed: 20128796
J Neurosci. 2007 May 9;27(19):5249-59
pubmed: 17494711
Proc Natl Acad Sci U S A. 2019 May 14;116(20):10019-10024
pubmed: 31036664
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153
pubmed: 30379577
J Biochem. 2019 Jun 1;165(6):459-464
pubmed: 30796426
Mol Pharmacol. 2015 Jul;88(1):161-70
pubmed: 25715797
Drug Discov Today. 2017 Jan;22(1):57-71
pubmed: 27506873
Trends Cancer. 2017 Feb;3(2):75-78
pubmed: 28718447
Pharmacol Rev. 2011 Sep;63(3):471-538
pubmed: 21752876
Mol Neurobiol. 2013 Feb;47(1):280-9
pubmed: 23054684
Neuropharmacology. 2019 May 1;149:149-160
pubmed: 30763657
Mol Neurobiol. 2016 Sep;53(7):4754-71
pubmed: 26328537
J Neurochem. 1999 Feb;72(2):565-75
pubmed: 9930728
Neuropharmacology. 2013 Feb;65:165-72
pubmed: 23041537
Expert Rev Neurother. 2016;16(2):123-30
pubmed: 26689339
J Neurochem. 2009 Jan;108(1):295-304
pubmed: 19012750
J Neuroimmunol. 2009 Mar 31;208(1-2):87-93
pubmed: 19203800
Neurotox Res. 2008 Dec;14(4):343-51
pubmed: 19073437
Stroke. 2004 Apr;35(4):981-6
pubmed: 15017017